Rice Hall James & Associates, LLC Nevro Corp Transaction History

Rice Hall James & Associates, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $879,068 - $1.81 Million	-12,517 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$76.41 - $117.54 $833,862 - $1.28 Million	-10,913 Reduced 46.58%	12,517 $1.47 Million
Q3 2019 Oct 30, 2019	SELL	$61.52 - $91.1 $706,188 - $1.05 Million	-11,479 Reduced 32.88%	23,430 $2.01 Million
Q2 2019 Aug 01, 2019	BUY	$58.04 - $66.99 $102,962 - $118,840	1,774 Added 5.35%	34,909 $2.26 Million
Q1 2019 May 01, 2019	BUY	$35.52 - $62.62 $792,522 - $1.4 Million	22,312 Added 206.15%	33,135 $2.07 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $383,458 - $609,226	10,823 New	10,823 $421,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.